The data from 2023 shows significant variation in female mortality rates from endocrine, nutritional, and metabolic diseases across countries. Mexico leads with a 34.86% share, showing a 5.27% increase from 2022. Other countries like Colombia, Peru, and Croatia exhibit notable increases at 12.31%, 10.54%, and 17.07%, respectively. However, countries such as Japan and South Korea reported decreases in their shares.
Future trends to watch include increasing mortality rates in emerging economies, possibly driven by lifestyle factors and healthcare disparities, while some developed countries may see stabilized or reduced rates due to improved health interventions and policies.
Top countries in Endocrine, Nutritional and Metabolic Diseases Mortality Share by Country (Units (Female Deaths))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Mexico | 34.86 | 2023 | +3.14% | +5.27% | View data |
| 2 | 2 South Africa | 9.84 | 2023 | +1.45% | +1.53% | View data |
| 3 | 3 Germany | 9.23 | 2023 | +0.47% | +0.9% | View data |
| 4 | 4 Japan | 5.02 | 2023 | +0.51% | -0.096% | View data |
| 5 | 5 Colombia | 4.64 | 2023 | +10.13% | +12.31% | View data |
| 6 | 6 Spain | 3.95 | 2023 | +0.9% | +2.43% | View data |
| 7 | 7 Poland | 3.28 | 2023 | +0.61% | +5.9% | View data |
| 8 | 8 Peru | 3.18 | 2023 | +9.24% | +10.54% | View data |
| 9 | 9 Argentina | 3 | 2023 | +0.67% | +0.95% | View data |
| 10 | 10 United Kingdom | 2.64 | 2023 | -0.053% | +2.4% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
